National Eye Institute Awards Dr. Ajay Sharma for Ocular Research
Dr. Ajay Sharma has been awarded a $1.71 million grant from the National Eye Institute (NEI) for a five-year research project to investigate the pathology of ocular Graft versus Host Disease (oGVHD). Dr. Sharma’s research will investigate the role of a specific type of immune cells called “macrophages” in oGVHD. About half of the oGVHD patients
On the CUSP: January 2023
Awards and Recognitions The Chapman/SCAN/Providence PGY1 Managed Care Residency was selected by the Greater Irvine Chamber for the Healthcare in Collaboration Award. An equal partnership between Chapman, SCAN Health Plan, and Providence Medical Foundation, the award was received by Dr. Jelena Lewis and accompanied by other Chapman representatives, including Dean Dr. Ren Ostrom, Associate Deans
PharmD Candidates at an Advantage in Hiring
Soon-to-be PharmD graduates are at an advantage as they enter the workforce, and can expect higher pay, significant signing bonuses, and increased flexibility as they begin their careers. Recent hiring trends are favoring those entering the medical industry, especially in retail and community pharmacies. Since last fall, recruiters have expanded their efforts to fill the
"Healthcare Collaboration of the Year" Awarded to Chapman Program
The Greater Irvine Chamber has awarded Chapman/SCAN/Providence PGY-1 Managed Care Residency program the Healthcare Collaboration of the Year Award at the Excellence in Healthcare Gala on January 26, 2023. Dr. Jelena Lewis, Director of Residency and Fellowship Programs at CUSP, accepted the award alongside Dr. Tri Tran from SCAN Health Plan and Dr. Caroline Vovan
Dr. Jerika Lam Receives Grant to Continue Search for HIV Prevention Outcomes
Gilead’s NOVA RFP has awarded Dr. Jerika Lam $82,871 to fund a clinical trial study on HIV prevention to produce outcomes that will help put an end to the HIV epidemic- A virus that has taken an estimated 40M lives globally. Dr. Lam’s award will fund her proposal, “Exploring barriers and facilitators to pharmacy-based HIV
On the CUSP: December 2022
The last month of 2022 brought on significant accomplishments to an already remarkable year for the Chapman University School of Pharmacy. In December, both students and faculty represented at the largest gathering of pharmacy professionals in the world, Dr. Amy Kang was named an ACCP Junior Investigator, and CUSP researchers authored articles on diverse topics
Dr. Amy Kang Named ACCP Futures Grant Awardee
The American College of Clinical Pharmacy (ACCP) has named Dr. Amy Kang, an assistant professor at Chapman Pharmacy, a recipient of the Futures Grant at the Junior Investigator level. This award titles Dr. Kang as one of the clinical pharmacy’s most promising early-career contributors to future clinical research. The grant will support her in continuing to
ASHP 2022: What happened in Vegas isn't staying in Vegas
Every year, pharmacy schools from across the nation gather at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition for educational programming, national posters, and presentations, and to be a part of one of the largest pharmaceutical conferences in the world. Chapman Pharmacy faculty and students triumphed (yet again) in all aspects
R03 Grant Recipient Dr. Sherif Elshahawi
Dr. Sherif Elshahawi has been declared a recipient of the R03 grant from NIH (National Institutes of Health) to continue his work inventing antibiotics that inhibit resistant bacteria to “last resort” antibiotics. Dr. Elshahawi received $138,000 from the NIAID (Award # 1R03AI168826-01A1) for his proposal titled “Mechanisms and In Vivo Activity of a Next Generation
On the CUSP: November 2022
That’s a wrap on November 2022! Chapman Pharmacy had an exceptionally busy month, including receiving the NIH R03 Grant and extensive participation in the California Society of Health-System Pharmacists (CSHP) 2022 Seminar. Grants Dr. Sherif Elshahawi became the recipient of the NIH R03 Grant (Award # 1R03AI168826-01A1) with a total amount of $138,000 from the